0001209191-22-007514.txt : 20220207 0001209191-22-007514.hdr.sgml : 20220207 20220207172042 ACCESSION NUMBER: 0001209191-22-007514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220204 FILED AS OF DATE: 20220207 DATE AS OF CHANGE: 20220207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shameze Rampertab CENTRAL INDEX KEY: 0001721810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 22598514 MAIL ADDRESS: STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP. STREET 2: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASENSUS SURGICAL, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 TW ALEXANDER DRIVE STREET 2: SUITE 160 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 1 TW ALEXANDER DRIVE STREET 2: SUITE 160 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX, INC. DATE OF NAME CHANGE: 20190712 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-04 0 0000876378 ASENSUS SURGICAL, INC. ASXC 0001721810 Shameze Rampertab C/O ASENSUS SURGICAL, INC. 1 TW ALEXANDER DRIVE, SUITE 160 DURHAM NC 27703 0 1 0 0 EVP, Chief Financial Officer Common Stock 2022-02-04 4 M 0 98608 0.00 A 110717 D Common Stock 2022-02-04 4 F 0 26711 0.80 D 84006 D Stock Options 0.80 2022-02-04 4 A 0 222500 0.00 A 2029-02-04 Common Stock 222500 222500 D Restricted Stock Units 0.00 2022-02-04 4 A 0 187250 0.00 A Common Stock 187250 187250 D Restricted Stock Units 0.00 2022-02-04 4 A 0 187250 0.00 A Common Stock 187250 187250 D Restricted Stock Units 0.00 2022-02-04 4 A 0 84270 0.00 A Common Stock 84270 84270 D Restricted Stock Units 0.00 2022-02-04 4 M 0 19704 0.00 D Common Stock 19704 39408 D Restricted Stock Units 0.00 2022-02-04 4 M 0 19704 0.00 D Common Stock 19704 39408 D Restricted Stock Units 0.00 2022-02-04 4 M 0 59200 0.00 D Common Stock 59200 0 D This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Vests one-third annually on each of February 4, 2023, 2024 and 2025, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement"). Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2023, 2024 and 2025, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. PRSU award with time-based vesting in three equal installments on each of February 4, 2023, 2024 and 2025, and performance-based vesting only if designated corporate goals are met. Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2023, as long as the Reporting Person remains in continuous service during the vesting period. Lapse of forfeiture on one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs in two equal installments on February 4, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs in two equal installments on each of February 4, 2023 and 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Lapse of forfeiture restrictions on a discretionary retention award made on February 8, 2021. /s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab 2022-02-07